Mediwhale - Latest News and Information
Mediwhale develops AI medical devices that analyze retinal images to predict cardiovascular, kidney, and eye disease risks early. The company has regulatory-approved solutions deployed in hospitals and clinics globally, with a focus on cardiometabolic disease prevention and low-radiation, quick retinal assessments. Based in Seoul, they market products such as Dr.Noon CVD, CKD, and Fundus, serving healthcare providers across regions including Korea, the UAE, the UK, and Italy.
No recent news for this company.
